Furthermore, our findings from the mouse xenograft model reflected an inhibitory effect of the Akt inhibitor SC66 on tumor formation and cell survival, and suggested that SC66 treatment sensitized cancer cells to cisplatin chemotherapy. The gene discussed is AKT1; the disease is cancer.